Title |
The p53/Adipose-Tissue/Cancer Nexus
|
---|---|
Published in |
Frontiers in endocrinology, August 2018
|
DOI | 10.3389/fendo.2018.00457 |
Pubmed ID | |
Authors |
Kevin Zwezdaryk, Deborah Sullivan, Zubaida Saifudeen |
Abstract |
Obesity and the resultant metabolic complications have been associated with an increased risk of cancer. In addition to the systemic metabolic disturbances in obesity that are associated with cancer initiation and progression, the presence of adipose tissue in the tumor microenvironment (TME) contributes significantly to malignancy through direct cell-cell interaction or paracrine signaling. This chronic inflammatory state can be maintained by p53-associated mechanisms. Increased p53 levels that are observed in obesity exacerbate the release of inflammatory cytokines that fuel cancer initiation and progression. Dysregulated adipose tissue signaling from the TME can reprogram tumor cell metabolism. The links between p53, cellular metabolism and adipose tissue dysfunction and how they relate to cancer, will be presented in this review. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 50% |
Switzerland | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 45 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 10 | 22% |
Researcher | 7 | 16% |
Student > Doctoral Student | 6 | 13% |
Student > Master | 5 | 11% |
Student > Bachelor | 4 | 9% |
Other | 5 | 11% |
Unknown | 8 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 15 | 33% |
Agricultural and Biological Sciences | 8 | 18% |
Medicine and Dentistry | 4 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 7% |
Engineering | 2 | 4% |
Other | 4 | 9% |
Unknown | 9 | 20% |